相关实验视频

Updated: Jan 15, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

REDD1减轻胆固醇性肝纤维化,并抑制PI3K/AKT/mTOR通路的发生

Xiaonan Li¹, Xin Liu², Xinrui Shi²

¹Department of Radiotherapy, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan, China.

Frontiers in medicine

|October 10, 2025

概括

肝纤维化,通常是由胆固醇形成引起的,缺乏有效的治疗方法. 这项研究发现,通过调节PI3K/AKT/mTOR通路,REDD1的上调可以令人惊地保护肝纤维化,这表明REDD1是治疗标.

科学领域:

肝病学肝病学是一种肝病学.
分子生物学分子生物学
纤维化研究纤维化研究

背景情况:

肝纤维化是一个重要的健康问题,特别是当与胆固醇结相关时.
对于胆固醇性肝纤维化目前的治疗选择有限.
了解肝纤维化背后的分子机制对于开发新疗法至关重要.

研究的目的:

研究REDD1基因在肝纤维化中的作用.
探索REDD1作为胆固醇性肝纤维化的潜在治疗标.

主要方法:

使用mRNA测序和RT-qPCR在胆道结合 (BDL) 的小鼠模型中识别REDD1.
免疫组织化学分析了REDD1,CD68,α-SMA和PI3K/AKT/mTOR通路标记物在原发性胆道胆炎 (PBC) 患者的肝脏组织中.
使用腺病毒介导的REDD1转染来评估体内治疗效果.

主要成果:

在BDL诱导的纤维性肝组织中,REDD1显著上调.
在PBC患者中,REDD1表达与纤维化标志物 (α-SMA,CD68) 正相关.
在BDL小鼠中,REDD1过度表达改善了肝损伤,降低了肝酶 (ALT/AST),降低了BDL小鼠的原沉积,这意味着补偿作用.

结论:

REDD1显示出对肝纤维化的保护作用,可能通过PI3K/AKT/mTOR通路.
REDD1代表了缓解肝纤维化的有希望的治疗标,特别是在胆固醇状况下.

关键词:

在PI3K/AKT/mTOR中使用.在REDD1中,REDD1是指REDD1.胆道结合胆道结合胆道结合肝脏纤维化肝脏纤维化一次性胆道胆道炎.

更多相关视频

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...